May M - Search Results

1

Does preoperative platelet count and thrombocytosis play a prognostic role in patients undergoing nephrectomy for renal cell carcinoma? Results of a comprehensive retrospective series.

Brookman-May S, May M, Ficarra V, Kainz MC, Kampel-Kettner K, Kohlschreiber S, Wenzl V, Schneider M, Burger M, Wieland WF, Otto W, Tilki D, Gilfrich C, Hohenfellner M, Pahernik S, Chromecki TF, Stief C, Zigeuner R; Members of the CORONA (Collaborative Research On Renal Neoplasms Association) Project. Brookman-May S, et al. Among authors: may m. World J Urol. 2013 Oct;31(5):1309-16. doi: 10.1007/s00345-012-0931-0. Epub 2012 Aug 19. World J Urol. 2013. PMID: 22903790

2

Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.

May M, Hakenberg OW, Gunia S, Pohling P, Helke C, Lübbe L, Nowack R, Siegsmund M, Hoschke B. May M, et al. Urology. 2007 Sep;70(3):449-53. doi: 10.1016/j.urology.2007.04.023. Epub 2007 Aug 3. Urology. 2007. PMID: 17688921 Clinical Trial.

3

Ki67 staining index and neuroendocrine differentiation aggravate adverse prognostic parameters in prostate cancer and are characterized by negligible inter-observer variability.

Gunia S, Albrecht K, Koch S, Herrmann T, Ecke T, Loy V, Linke J, Siegsmund M, May M. Gunia S, et al. Among authors: may m. World J Urol. 2008 Jun;26(3):243-50. doi: 10.1007/s00345-008-0257-0. Epub 2008 Apr 5. World J Urol. 2008. PMID: 18392627

4

Evaluation of renicapsular involvement in Stages I and II renal cell carcinoma from the morphological and prognostic point of view.

May M, Brookman-Amissah S, Roigas J, Gilfrich CP, Pflanz S, Hoschke B, Gunia S. May M, et al. Urol Oncol. 2010 May-Jun;28(3):274-9. doi: 10.1016/j.urolonc.2008.07.008. Epub 2008 Sep 21. Urol Oncol. 2010. PMID: 18805709

5

Impact of macroscopic tumour necrosis to predict survival of patients with surgically resected renal cell carcinoma.

Pflanz S, Brookman-Amissah S, Roigas J, Kendel F, Hoschke B, May M. Pflanz S, et al. Among authors: may m. Scand J Urol Nephrol. 2008;42(6):507-13. doi: 10.1080/00365590802460633. Scand J Urol Nephrol. 2008. PMID: 19031267

6

Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications.

May M, Brookman-Amissah S, Roigas J, Hartmann A, Störkel S, Kristiansen G, Gilfrich C, Borchardt R, Hoschke B, Kaufmann O, Gunia S. May M, et al. Eur Urol. 2010 May;57(5):850-8. doi: 10.1016/j.eururo.2009.03.052. Epub 2009 Mar 31. Eur Urol. 2010. PMID: 19346063

7

Post-void residual urine as a predictor of urinary tract infection--is there a cutoff value in asymptomatic men?

May M, Brookman-Amissah S, Hoschke B, Gilfrich C, Braun KP, Kendel F. May M, et al. J Urol. 2009 Jun;181(6):2540-4. doi: 10.1016/j.juro.2009.01.103. Epub 2009 Apr 16. J Urol. 2009. PMID: 19375097

8

Validation of a postoperative prognostic model consisting of tumor microvascular invasion, size, and grade to predict disease-free and cancer-specific survival of patients with surgically resected renal cell carcinoma.

May M, Brookman-Amissah S, Kendel F, Knoll N, Roigas J, Hoschke B, Miller K, Gilfrich C, Pflanz S, Gralla O. May M, et al. Int J Urol. 2009 Jul;16(7):616-21. doi: 10.1111/j.1442-2042.2009.02319.x. Epub 2009 May 13. Int J Urol. 2009. PMID: 19456988

9

Urinary collecting system invasion reflects adverse long-term outcome and is associated with simultaneous metastatic spread at the time of surgery and with multilocular dissemination during postsurgical follow-up in renal cell cancer.

Brookman-Amissah S, May M, Albrecht K, Herrmann T, Roigas J, Gilfrich CP, Pflanz S, Gunia S. Brookman-Amissah S, et al. Among authors: may m. World J Urol. 2010 Feb;28(1):103-9. doi: 10.1007/s00345-009-0426-9. Epub 2009 May 29. World J Urol. 2010. PMID: 19479264

10

Ten-year survival analysis for renal carcinoma patients treated with an autologous tumour lysate vaccine in an adjuvant setting.

May M, Brookman-May S, Hoschke B, Gilfrich C, Kendel F, Baxmann S, Wittke S, Kiessig ST, Miller K, Johannsen M. May M, et al. Cancer Immunol Immunother. 2010 May;59(5):687-95. doi: 10.1007/s00262-009-0784-6. Epub 2009 Oct 30. Cancer Immunol Immunother. 2010. PMID: 19876628 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,163 results

Search Page